Clinical Trial Update: Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

This entry notes completion of a Phase 1 trial evaluating a novel peptide vaccination for advanced renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Novel Peptide Vaccination

Snippet

Sponsor: Iwate Medical University | Conditions: Renal Cell Carcinoma | Phase 1 | Status: COMPLETED